TD Cowen Maintains Buy on Johnson & Johnson, Raises Price Target to $300

Benzinga Newsdesk www.benzinga.com Positive 89.3%

Neg 0% Neu 0% Pos 89.3%

TD Cowen analyst Michael Nedelcovych maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $250 to $300.